Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Pfizer
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Bristol-Myers Squibb
Seagen Inc.
Genmab
Eli Lilly and Company
Pfizer
Dana-Farber Cancer Institute
PMV Pharmaceuticals, Inc
Merck Sharp & Dohme LLC
Verastem, Inc.
National Institutes of Health Clinical Center (CC)
Merck Sharp & Dohme LLC
IFOM ETS - The AIRC Institute of Molecular Oncology
Neonc Technologies, Inc.
Pfizer
Seagen Inc.
Tizona Therapeutics, Inc
Essen Biotech
Genentech, Inc.